Benign mesenchymal stromal cells in human sarcomas.

Area of Science:

• Oncology
• Cell Biology
• Stem Cell Research

Background:

• Sarcomas are cancers originating from connective tissues.
• Mesenchymal stromal cells (MSCs) are implicated in sarcoma development.
• MSCs have not been previously isolated directly from human sarcoma specimens.

Purpose of the Study:

• To investigate the presence and characteristics of MSCs within human sarcoma specimens.
• To determine if MSCs isolated from sarcomas exhibit properties similar to those from normal tissues.
• To explore the potential role of these cells in sarcoma progression.

Main Methods:

• Analysis of human sarcoma cell lines and primary cultures for MSC features.
• Characterization of primary cultures using genetic markers and tumor formation assays in mice.
• Immunophenotyping and differentiation potential assessment of sarcoma-derived cells.
• Co-culture experiments with sarcoma cell lines and normal pericytes.

Main Results:

• A liposarcoma cell line demonstrated MSC trilineage differentiation potential.
• Primary sarcoma cultures exhibited MSC morphology, immunophenotype, and differentiation capacity.
• Many primary cultures were benign, lacking tumor-forming ability and genetic lesions.
• Sarcoma-derived benign MSCs (SDBMSCs) expressed pericyte markers and supported tube formation with endothelial cells.
• In sarcoma tissues, pericytes expressed MSC markers, unlike malignant cells.
• SDBMSCs and normal pericytes enhanced sarcoma cell line growth in vitro.

Conclusions:

• Sarcoma-derived benign MSCs/pericytes represent a novel stromal cell type in sarcomas.
• These cells may play a role in the development and progression of sarcomas.
• Further research is warranted to elucidate the precise mechanisms of their contribution to tumorigenesis.